44 results about "Cerebral embolus" patented technology

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. The deflector shaft could have a first portion and a second portion, the second portion being more flexible than the first portion. The deflector frame can include one, two, or more movable structures, such as hinges. Also disclosed are methods for insertion and removal of the deflector.

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (greater than 100 microns in the preferred embodiment) from entering either the right or left carotid arteries by deflecting emboli downstream in the blood flow. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The device has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the device.

There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.

The invention belongs to the technical field of medicaments and provides active ingredients of Chinese herbal medicine camptosorus sibiricus and an extraction method and use of the same. The extraction method comprises a water extraction method, an alcohol extraction method, a macroporous resin purification method and a solvent extraction method. The main active ingredients of an extract obtained by the method are total flavonoids, total momordica saponins and total organic acids, wherein the content of the total flavonoids is 1 to 35 percent, the content of the total momordica saponins is 1 to 25 percent and the content of the total organic acids is 1 to 3 percent. The invention also provides a method for preparing the camptosorus sibiricus into a proper formulation directly or by mixing with solid or liquid commonly used for preparations of the type in pharmaceutics. The active ingredients of the camptosorus sibiricus and the preparation thereof have functions of treating thromboangiitis obliterans, nephritis, traumatism and bleeding, metrorrhagia, neurodermitis, hemiplegia caused by cerebral embolism and diabetes-related complications. The extraction method is simple, easy to implement and low in cost. And the extract obtained is free from toxic and side effects.

The present invention belongs to the field of pharmaceutical technology and relates to transdermal Ligustrazine plaster and its preparation. It has Ligustrazine phosphate or Ligustrazine as active medicinal component and consists of medicine storing back, adhering layer, release controlling film, back lining layer and protective layer. It is superior to available Ligustrazine preparation forms inmedicine releasing are, transdermal rate and lasting release time, and has the features of determined curative effect, stable quality, high safety, etc. Animal experiments show that the plaster can retard the effect of ischemic to cerebral damage, inhibit thrombosis caused by tissue damage, prevent and treat cerebral embolism and maintain balanced medicine density in blood for 24 hr; and has light irritation to skin, no irritability and no toxic reaction.

The invention provides a traditional Chinese medicine compound used for treating cardiovascular and cerebrovascular diseases, which is made of the following components by weight ratios: 5-25 portions of red sage root, 5-25 portions of astragalus root, 5-25 portions of pseudostellaria root, 3-23 portions of polygala aureocauda dunn, 3-23 portions of shepherds purse, 1-6 portions of notoginseng, 3-23 portions of oldenlandia, 3-23 portions of eucommia bark, 3-23 portions of prepared rehmannia root, and 1-6 portions of prepared licorice. The components of the traditional Chinese medicine compound can produce synergetic effect, thus treating the cardiovascular and cerebrovascular diseases with high efficiency. Clinical control studies prove that the traditional Chinese medicine compound has the total effective rate of 96.9% on treating cerebral embolism and the total effective rate of 100% on treating hypertension. Also, the traditional Chinese medicine compound has the advantages of quick effect and good and lasting curative effect.

The invention discloses application of (E)-2-(3,5-dimethoxybenzylidene)-cyclopentanone in preparing a medicine for treating cerebrovascular diseases. The related research indicates that the compound has an obvious cranial nerve protection effect, obviously reduces the focal cerebral ischemia rat cerebral infarction volume and remarkably improves the neurologic symptom. The (E)-2-(3,5-dimethoxybenzylidene)-cyclopentanone is used for preventing or treating the diseases such as ischemic brain injury, cerebral hemorrhage, cerebral thrombosis, cerebral embolism, cerebral infarction, cerebral apoplexy, lacunar infarction, transient ischemic attack, cerebral arteriosclerosis, diabetic cerebrovascular complications and the like.

The invention discloses a medicinal composition for treating cardiovascular and cerebrovascular diseases, and a preparation method and application of the medicinal composition. The medicinal composition can prolong coagulation time, reduce cholesterol levels and contribute to reducing the formation rate of thrombus and atherosclerosis, can be used for treating cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and the like, and cardiovascular diseases such as coronary disease, hypertension, hyperlipaemia, atherosclerosis, myocardial ischemia, arrhythmia, heart failure, stenocardia, myocardial infarction and the like, particularly has good treatment effect when used for continued treatment on patients suffering the cardiovascular and cerebrovascular diseases after emergency treatment, and is a new choice for clinical medication.

The invention belongs to the technical field of medicine and discloses a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases. The pharmaceutical composition is prepared by ginsenoside and carithamine as main ingredients and can be prepared into pharmaceutically or clinically acceptable dosage forms. The pharmaceutical composition has functions of expanding blood vessels of brain, reducing cerebral vascular resistance, increasing cerebral blood flow, obviously minimizing infarct area of brain tissues, obviously lightening behavior disorders caused by brain tissue necrosis, and the like, and can be used for preparing medicaments for treating diseases such as cerebral circulation insufficiency, cerebral thrombosis, cerebral embolism, brain blood vessels spasm, brain insufficiency, senile dementia, Parkinsonism, cerebral apoplexy, hypertension, hyperlipemia, arteriosclerosis, coronary heart disease, angina pectoris, miocardial infarction, etc.

The invention discloses application of salvianolic acid A in preparation of a drug for treating cerebral hemorrhage. Cerebral hemorrhage comprises simple cerebral hemorrhage stroke, hemorrhage after cerebral embolism and hemorrhage caused by thrombolytic drug treatment and other factors. Experimental research finds that salvianolic acid A can significantly reduce the cerebral infarction volume andencephaledema of rats, improve neurological functions and protect blood-brain barrier damage caused by thrombolytic drugs such as t-PA, thereby reducing the risk and degree of hemorrhagic transformation when the thrombolytic drugs are used. The salvianolic acid A can be used for preparing the drug for treating cerebral hemorrhage and hemorrhage caused by thrombolytic drug treatment, relieving secondary hemorrhage in ischemic areas and improving prognosis of patients.

A medicine in the form of dispersing tablet for treating apoplexy, coronary heart disease, cerebral infarction, etc is proportionally prepared from tribulus saponin, cross-linked polyvinyl pyrrolidone, low-substituted hydroxypropyl cellulose and/or carboxymethyl cellulose sodium, carboxymethyl starch sodium, hydroxypropyl cellulose, microcrystalline cellulose, magnesium stearate, and micropowdered silica gel or SiO2.

The invention relates to applications of ozonized oil in prevention and treatment of ischemic cardiovascular and cerebrovascular diseases, chronic gastritis and type 2 diabetes as well as combined medication of medicines for treating the diseases. The invention particularly relates to applications of ozonized oil in prevention and treatment of coronary occlusion, angina pectoris, arrhythmia, premature beat, arrhythmia, cerebral infarction (including cerebral embolism and cerebral thrombosis), cerebral hemorrhage, cardiovascular and cerebrovascular atherosclerosis, chronic gastritis (including superficial gastritis, atrophic gastritis and erosive gastritis) and type 2 diabetes by virtue of an oral administration route.

The invention relates to the technical field of medical equipment, and discloses nursing equipment for assisting limb movement of a cerebral embolism patient. The nursing equipment comprises a frame body, a sliding platform is movably connected to the interior of the frame body, the front surface of the sliding platform is movably connected with a positioning platform, a driving mechanism is movably connected to the front face of the positioning platform, a limiting frame is movably connected to the left side of the driving mechanism, a connecting rod is movably connected into the limiting frame, a return spring is movably connected to the outer side of the connecting rod in a sleeving mode, and a self-locking mechanism is movably connected to the left side of the limiting frame. Accordingto the nursing equipment, through the advantages of constant advancing distance and self-locking, the strides of the patient are consistent all the time when the limb training movement is conducted,the muscle memory of the patient can be effectively improved, meanwhile, the patient can be prevented from falling down due to backward leaning through the self-locking design, and the use safety of the equipment is improved.

The invention discloses application of 5-(3', 5'-dimethoxybenzylidene)-2-sulfo-imidazole-4-one to preparation of drugs for treating cerebrovascular diseases. According to relevant researches disclosed by the invention, the compound has a remarkable cerebral nerve protection effect, can obviously reduce the volume of cerebral infarction of a focal cerebral ischemia rat and can obviously improve neurological signs; and moreover, the protection effect of an IV4 compound to cerebral ischemic injuries is related to the inhibition of the activation of lysosomal enzyme cathepsin B, so that the compound can be used for preparing drugs for preventing or treating diseases such as ischemic brain injuries, cerebral hemorrhage, cerebral thrombosis, cerebral embolism, cerebral infarction, cerebral stroke, lacunar infarction, transient ischemia attacks, cerebral arteriosclerosis and diabetic cardiovascular complications.

The invention relates to an acanthopanax root, schisandra chinensis and xylitol healthy beverage and a preparation method thereof. The preparation method specifically comprises a formula, a preparation method and an application thereof. The formula and the preparation method are designed for developing health management and service in cooperation, facilitating application and ensuring the safety and health-care function of the composition; aiming at consumption groups of middle-aged and elderly patients suffering from coronary heart disease, cerebral embolism, cerebral hemorrhage, hypertension, diabetes mellitus complicated with double heart disease (cardiac neurosis), the beverage has the health-care functions of improving sleep and glycometabolism, reducing clinical risk factors, reducing drug dosage and the like. A health management and health service technical scheme is added, the health service capability of traditional Chinese medicine is improved, the construction of a complete large health industry chain and healthy beverage industry specifications is accelerated, and the industrialization, standardization, health and internationalization development of medicinal and edible substances is promoted.

The invention discloses a medicine composition for treating cerebrovascular and cardiovascular diseases as well as a preparation method and an application of the medicine composition. The medicine composition can resist thrombosis and blood stasis and can be used treating cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and the like and cardiovascular diseases such as coronary heart disease, hypertension, hyperlipidemia, atherosclerosis, atherosclerosis, arrhythmia, heat failure, angina, myocardial infarction and the like. The medicine composition is especially used for continuously treating patients with cerebrovascular and cardiovascular diseases after emergency treatment and has good curative effects, and a new choice is provided for clinical medication.

The invention discloses a Chinese patent medicine for cerebral infarction. The Chinese patent medicine is prepared from the following raw materials in terms of parts by weight: 10 to 18 parts of anisetree bark, 8 to 17 parts of fewflower lysionotus herb, 8 to 15 parts of cortex phellodendri amurensis, 10 to 15 parts of rhizoma atractylodis, 6 to 12 parts of achyranthes root, 5 to 12 parts of semen sesami nigrum, 5 to 12 parts of waxgourd seed, 2 to 8 parts of honeysuckle flower, 1 to 6 parts of hedyotis hedyotidea, 2 to 8 parts of turtle shell, 1 to 7 parts of radix platycodonis, 2 to 10 parts of alum and 1 to 6 parts of myrrh. The Chinese patent medicine for cerebral infarction has the advantages that the recovery from lacunar infarction and cerebral-embolism-type cerebral infarction is promoted by means of promoting blood circulation, dispersing blood stasis, cooling blood and stopping bleeding, and an excellent curative effect is obtained through clinical practice.